Cellbricks Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $10M

  • Investors
  • 15

Cellbricks Therapeutics General Information

Description

Developer of a bio-fabrication platform intended to address the global challenge of organ shortage and the need for improved in-vitro models. The company's platform helps the industrial production of large and complex structures, seamlessly integrating different biomaterials and cell varieties, enabling medical researchers to provide their patients with improved clinical treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Müllerstrasse 178
  • 13353 Berlin
  • Germany
+49 030
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Müllerstrasse 178
  • 13353 Berlin
  • Germany
+49 030

Cellbricks Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellbricks Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 25-Mar-2026 $10M Completed Pre-Clinical Trials
6. Accelerator/Incubator 01-Sep-2024 Completed Pre-Clinical Trials
5. Seed Round 23-Apr-2024 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2022 Completed Product In Beta Test
3. Seed Round 05-Sep-2019 Completed Product In Beta Test
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view Cellbricks Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cellbricks Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bio-fabrication platform intended to address the global challenge of organ shortage and the need for impr
Biotechnology
Berlin, Germany
30 As of 2026

Pessac, France
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cellbricks Therapeutics Competitors (7)

One of Cellbricks Therapeutics’s 7 competitors is Treefrog Therapeutics, a Venture Capital-Backed company based in Pessac, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Treefrog Therapeutics Venture Capital-Backed Pessac, France
Trestle Biotherapeutics Venture Capital-Backed San Diego, CA
Satellite Bio Venture Capital-Backed Newton, MA
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
Egenesis Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 7 competitors. Get the full list »

Cellbricks Therapeutics Patents

Cellbricks Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025031537-A1 Method for producing an ink for 3d printing using a polypeptide based on human collagen with a reduced hydroxyproline content Inactive 04-Aug-2023
DE-102023120769-A1 Method for producing an ink for 3d printing using a polypeptide based on human collagen with reduced hydroxyproline content Active 04-Aug-2023
EP-4501955-A1 Polypeptide for 3d printing ink Pending 04-Aug-2023
WO-2025031978-A1 Polypeptide for an ink for 3d printing Inactive 04-Aug-2023
DE-102022132519-A1 3d adipose tissue scaffold produced by light-based structuring curing for use as breast implant Pending 07-Dec-2022 A61L27/3804
To view Cellbricks Therapeutics’s complete patent history, request access »

Cellbricks Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellbricks Therapeutics Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invest in Healthcare Family Office Minority
Riceberg Ventures Venture Capital Minority
Silicon Roundabout Ventures Venture Capital Minority
SPRIN-D Government
Startup Angels Alb-Bodensee Angel Group Minority
You’re viewing 5 of 15 investors. Get the full list »

Cellbricks Therapeutics FAQs

  • When was Cellbricks Therapeutics founded?

    Cellbricks Therapeutics was founded in 2015.

  • Where is Cellbricks Therapeutics headquartered?

    Cellbricks Therapeutics is headquartered in Berlin, Germany.

  • What is the size of Cellbricks Therapeutics?

    Cellbricks Therapeutics has 30 total employees.

  • What industry is Cellbricks Therapeutics in?

    Cellbricks Therapeutics’s primary industry is Biotechnology.

  • Is Cellbricks Therapeutics a private or public company?

    Cellbricks Therapeutics is a Private company.

  • What is Cellbricks Therapeutics’s current revenue?

    The current revenue for Cellbricks Therapeutics is .

  • How much funding has Cellbricks Therapeutics raised over time?

    Cellbricks Therapeutics has raised $10M.

  • Who are Cellbricks Therapeutics’s investors?

    Invest in Healthcare, Riceberg Ventures, Silicon Roundabout Ventures, SPRIN-D, and Startup Angels Alb-Bodensee are 5 of 15 investors who have invested in Cellbricks Therapeutics.

  • Who are Cellbricks Therapeutics’s competitors?

    Treefrog Therapeutics, Trestle Biotherapeutics, Satellite Bio, Aspect Biosystems, and Egenesis are some of the 7 competitors of Cellbricks Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process